Junetechevents

The strategic partnership between Mastek and Onyx Health marks a significant move in the healthcare sector, aiming to strengthen both companies' positions and expand their customer base. By leveraging Onyx Health’s OnyxOS platform and Mastek’s expertise in consulting and implementation, the partnership is set to improve data interoperability and compliance with healthcare regulations, specifically the CMS-9115 and CMS-0057 rules. This collaboration is likely to help both companies attract new customers and solidify their standing in the healthcare industry. Additionally, this move could set a precedent, prompting competitors to explore similar partnerships in a bid to keep up with industry advancements. Read More:  https://www.techdogs.com/tech-news/td-newsdesk/mastek-onyx-health-partner-to-boost-data-interoperability

  As the electric vehicle (EV) market expands, automakers are increasingly driven to secure cost-effective and more powerful batteries to stay competitive and maintain production plans. To this end, General Motors (GM) has taken significant steps to develop high-performance and affordable batteries, including a new partnership with leading battery manufacturer Samsung SDI. So, what’s the agreement between GM and Samsung SDI all about? Let’s dive in! What Is the General Motors and Samsung SDI Agreement About? Samsung SDI recently announced through a press release that it has finalized an agreement with General Motors to form a joint venture to supply EV batteries in the United States. The two companies met multiple times in 2023 to discuss the partnership, reaching an agreement in April of that year. The agreement was officially signed at Samsung SDI's office in Seoul. Under this partnership, both companies will invest approximately $3.5 billion. The joint venture will establish a n...

  The recent discovery of a zero-day vulnerability by Black Lotus Labs, the threat research arm of Lumen Technologies, has once again highlighted the critical need for more rigorous and comprehensive testing of platforms and their updates, especially those used by network providers, Internet service providers (ISPs), managed service providers (MSPs), and other IT organizations. The vulnerability, identified as CVE-2024-39717, was found in Versa Director, a platform integral to the creation, automation, and delivery of services using Versa solutions. The exploitation of this vulnerability underscores the potential dangers that arise when platforms do not undergo adequate testing before being deployed. In the case of Versa Director, the vulnerability affected all versions prior to 22.1.4 and was tied to a custom-tailored web shell, dubbed "VersMem" by the researchers. This web shell was used to intercept and harvest credentials, allowing attackers to gain unauthorized access to...